The Effect of Rosa damascena on Children’s Enuresis: A Randomized Pilot Study
Abstract
Background and Aim: Enuresis is one of the common problems among children. The present pilot study was conducted to investigate the effect of Rosa damascene on nocturnal enuresis in children. Materials and Methods: A randomized pilot study was performed from April 2017 to March 2018. The study participants were 40 children aged between 5-12 years with nocturnal enuresis. They were randomly divided to intervention and control groups using block randomization. The intervention group received R. damascena petals under the brand name Gole-Ghand (Barij- essence, Iran) as 5 cc orally, every 8 hours for one month. The control group received desmopressin as nasal spray (Sina Darou, Iran) 1-2 puffs for one month (maximum 20 mg daily). The primary outcome was complete or partial improvement in enuresis. The secondary outcome was frequency of side effects in patients. Results: Twenty-two out of 39 patients 22 (56.4%) were male and 17 patients (43.6%) were female with the average age of 7.3±1.86 years. There was no noticeable distinction between the groups in age, sex, urbanity, history of treatment, and primary or secondary enuresis (p>0.05). Complete improvement was observed in 14 patients (70%) in the control group. Partial improvement was observed in four patients (20%) in the control group and in six patients (31.5%) in the intervention group (p:0.001). No side effect was reported during the study in the intervention group. Conclusion: Based on the results of this pilot study, the use of R. damascena may lead to partial improvement against enuresis in some children. Further studies are required to evaluate this hypothesis.References
Ferrara P, Franceschini G, Bianchi Di Castelbianco F, Bombace R, Villani A, Corsello G. Epidemiology of enuresis: a large number of children at risk of low regard. Italian journal of pediatrics. 2020;46(1):1-5.
von Gontard A, Equit M. Comorbidity of ADHD and incontinence in children. European child & adolescent psychiatry. 2015;24(2):127-40.
Von Gontard A, Pirrung M, Niemczyk J, Equit M. Incontinence in children with autism spectrum disorder. Journal of Pediatric Urology. 2015;11(5):264. e1-. e7.
Kiddoo DA. Nocturnal enuresis. Cmaj. 2012;184(8):908-11.
Kajiwara M, Inoue K, Kato M, Usui A, Kurihara M, Usui T. Nocturnal enuresis and overactive bladder in children: an epidemiological study. International Journal of Urology. 2006;13(1):36-41.
Deshpande AV, Caldwell PH, Sureshkumar P. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database of Systematic Reviews. 2012(12).
Kuwertz-Bröking E, von Gontard A. Clinical management of nocturnal enuresis. Pediatric Nephrology. 2018;33(7):1145-54.
Elsayed ER, Abdalla MM, Eladl M, Gabr A, Siam AG, Abdelrahman HM. Predictors of severity and treatment response in children with monosymptomatic nocturnal enuresis receiving behavioral therapy. Journal of pediatric urology. 2012;8(1):29-34.
Peng CC-H, Yang SS-D, Austin PF, Chang S-J. Systematic review and meta-analysis of alarm versus desmopressin therapy for pediatric monosymptomatic enuresis. Scientific reports. 2018;8(1):1-10.
Yuksek M, Erdem A, Atalay C, Demirel A. Acupressure versus oxybutinin in the treatment of enuresis. Journal of International Medical Research. 2003;31(6):552-6.
Park SJ, Park JM, Pai KS, Ha TS, Lee SD, Baek M. Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study. Pediatric Nephrology. 2014;29(7):1195-200.
Odeh M, Oliven A. Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis. The Journal of Clinical Pharmacology. 2001;41(5):582-4.
Thumfart J, Roehr C-C, Kapelari K, Querfeld U, Eggert P, Müller D. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors? The Journal of urology. 2005;174(1):294-8.
Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MFR, Menefee SA, et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. New England Journal of Medicine. 2012;367(19):1803-13.
Siddiqui JA, Qureshi SF, Allaithy A, Mahfouz TA. Nocturnal enuresis: a synopsis of behavioral and pharmacological management. Sleep and Hypnosis (Online). 2019;21(1):16-22.
Swamy P, Prasad V, Krishna B, Rao T, Kumar L, Rao G. In vitro anticholinergic activity of selected culinary spices on sheep airway smooth muscle. International Journal of Recent Scientific Research. 2013;4(5):649-53.
Zaveri M, Khandhar A, Patel S, Patel A. Chemistry and pharmacology of Piper longum L. International journal of pharmaceutical sciences review and research. 2010;5(1):67-76.
Irina B, Maria-Magdalena Z, Ioan B. Chemical composition of essential oils from Mentha aquatica L. at different moments of the ontogenetic cycle. Journal of Medicinal Plants Research. 2013;7(9):470-3.
Labban L, Thallaj N. The medicinal and pharmacological properties of Damascene Rose (Rosa damascena): A review. Int J Herb Med. 2020;8:33-7.
Boskabady MH, Shafei MN, Saberi Z, Amini S. Pharmacological effects of Rosa damascena. Iranian journal of basic medical sciences. 2011;14(4):295.
Akram M, Riaz M, Munir N, Akhter N, Zafar S, Jabeen F, et al. Chemical constituents, experimental and clinical pharmacology of Rosa damascena: a literature review. Journal of Pharmacy and Pharmacology. 2020;72(2):161-74.
Nayebi N, Khalili N, Kamalinejad M, Emtiazy M. A systematic review of the efficacy and safety of Rosa damascena Mill. with an overview on its phytopharmacological properties. Complementary therapies in medicine. 2017;34:129-40.
Caldwell PH, Deshpande AV, Von Gontard A. Management of nocturnal enuresis. Bmj. 2013;347.
24. Whitehead A, Julious S, Cooper C, Campbell M. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Statistical Methods in Medical Research. 2016; 25(3): 1057–173.
Viechtbauer W, Smits L, LucBudé D, Spigt M, Serroyen J, Crutzen R. A simple formula for the calculation of sample size in pilot studies. Journal of clinical epidemiology. 2015. 68 (11): 1375-79.
Boskabady M, Kiani S, Rakhshandah H. Relaxant effects of Rosa damascena on guinea pig tracheal chains and its possible mechanism (s). Journal of ethnopharmacology. 2006;106(3):377-82.
Sadraei H, Asghari G, Emami S. Inhibitory effect of Rosa damascena Mill flower essential oil, geraniol and citronellol on rat ileum contraction. Research in Pharmaceutical Sciences. 2013;8(1):17.
Friedman B-C, Friedman B, Goldman RD. Oxybutynin for treatment of nocturnal enuresis in children. Canadian Family Physician. 2011;57(5):559-61.
Ghasemi K, Esteghamati M, Mohammadzadeh M, Zare S. Desmopressin versus oxybutynin for nocturnal enuresis in children in Bandar Abbas: a randomized clinical trial. Electronic Physician. 2016;8(3):2187.
Lovering JS, Tallett SE, McKendry JB. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics. 1988;82(1):104-6.
Lee YB, Lee JA, Jang S, Lee HL. Herbal medicine (Suoquan) for treating nocturnal enuresis: A protocol for a systematic review of randomized controlled trials. Medicine. 2018;97(17).
Jo H-J, Lee J-Y, Kim D-G. The clinical study on the effect of radix ephedrae on the nocturnal enuresis in Korean children. The Journal of Pediatrics of Korean Medicine. 2001;15(1):155-64.
Schloss J, Ryan K, Steel A. A randomised, double-blind, placebo-controlled clinical trial found that a novel herbal formula Urox®(Bedtime Buddy®) assisted children for the treatment of nocturnal enuresis. Phytomedicine. 2021;93:153783.
Motaharifard MS, Effatpanah M, Nejatbakhsh F. Nocturnal enuresis in children and its herbal remedies in medieval persia: a narrative review. Journal of Pediatrics Review. 2020;8(1):15-22.
Sharifi H, Minaie MB, Qasemzadeh MJ, Ataei N, Gharehbeglou M, Heydari M. Topical use of Matricaria recutita L (Chamomile) oil in the treatment of monosymptomatic enuresis in children: a double-blind randomized controlled trial. Journal of evidence-based complementary & alternative medicine. 2017;22(1):12-7.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.
